Invo Bioscience Inc   (INVO)
Other Ticker:  


Invo Bioscience Inc

INVO's Financial Statements and Analysis

Invo Bioscience Inc narrowed III. Quarter net loss per share of $-0.21 compare to net loss per share of $-0.24 recorded in the same quarter a year ago and improved compare to net loss per share of $-0.23 realized in previous quarter.

III. Quarter
Earnings Per Share Revenues
$ -0.21 $  0 Mill
$+0.03     Unch.     +7.51 %

Invo Bioscience Inc 's Revenue rose by 7.51 % in III. Quarter (Sep 30 2022) year on year, to $0 million and advanced by 61.03 % sequentially.

Invo Bioscience Inc is Expected to report next financial results on March 30, 2023.

More on INVO's Income Statement

Invo Bioscience Inc 's in III. Quarter recorded net loss of $-2.550 million, an increase from net loss of $-2.481 million in III. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-2.802 million realized in previous quarter.

More on INVO's Growth

Inventories declined by -3.53 % to $0.28 million from III. Quarter a year ago, sequentially inventories fell by -0.66 %. In III. Quarter company's net cash and cash equivalents decreased by $-2 million, capital expenditures grew by -99.59%, to $0 millions compare to same quarter a year ago and rose by -28.40% from II. Quarter (Jun 30 2022).

More on INVO's Cash flow Statement

Invo Bioscience Inc does not pay out common stock dividend.

In trailing twelve-month period Invo Bioscience Inc payed $ -0.58 cash per share, on a free-cash flow basis .